Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.3K Hold
75
0.01% 222
2025
Q4
$17.1K Hold
75
0.01% 210
2025
Q3
$17.4K Hold
75
0.01% 205
2025
Q2
$13.9K Sell
75
-8
-10% -$1.49K 0.01% 217
2025
Q1
$17.4K Hold
83
0.01% 169
2024
Q4
$14.7K Hold
83
0.01% 193
2024
Q3
$16.4K Hold
83
0.01% 183
2024
Q2
$14.2K Buy
83
+45
+118% +$7.45K 0.01% 193
2024
Q1
$6.92K Hold
38
﹤0.01% 293
2023
Q4
$5.89K Buy
+38
New +$5.54K ﹤0.01% 271
2023
Q2
Sell
-17
Closed -$2.71K 548
2023
Q1
$2.71K Sell
17
-149
-90% -$22.8K ﹤0.01% 382
2022
Q4
$26.8K Buy
+166
New +$25.5K 0.02% 154
2021
Q4
Sell
-180
Closed -$24K 68
2021
Q3
$24K Buy
+180
New +$20.6K 0.02% 146

Other funds holding ABBV

Red Tortoise LLC's ABBV Position: Q1 2026 in Review

Red Tortoise LLC held its AbbVie (ABBV) position steady in Q1 2026 at 75 shares worth $16.3K. The position accounts for 0.01% of the portfolio, ranked #222.

Red Tortoise LLC first reported a position in ABBV in Q3 2021 and has held it in 13 quarters since. The position peaked at $26.8K in Q4 2022. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Red Tortoise LLC held 75 shares of AbbVie worth $16.3K as of Q1 2026.
  • Red Tortoise LLC left its AbbVie share count unchanged in Q1 2026.
  • AbbVie made up 0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #222 holding.
  • Red Tortoise LLC first reported a position in AbbVie in Q3 2021 and has held it in 13 quarters since.
  • Red Tortoise LLC's AbbVie position peaked at $26.8K in Q4 2022.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.